Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2020-05-15FDA Approved: OCREVUS — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Ocrevus (ocrelizumab) from Genentech, Inc., resulting in labeling changes for its multiple scler…